Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 4Phase 1/2 2Phase NA 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 2Myeloid 1

Conditions

Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Leukemia, Myeloid, Acute 6Medulloblastoma 5Lymphoma 5Sarcoma 4Hematologic Neoplasms 4Central Nervous System Neoplasms 4Brain Neoplasms 4Astrocytoma 4Rhabdoid Tumor 3Ovarian Neoplasms 3Glioma 3Ependymoma 3Burkitt Lymphoma 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Rhabdomyosarcoma 2Retinoblastoma 2Primary Myelofibrosis 2Pinealoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Myeloproliferative Disorders 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Liver Neoplasms 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Cyclophosphamide 17fludarabine 16fludarabine phosphate 11Azacitidine 9venetoclax 8Rituximab 8Nivolumab 7Melphalan 7Tacrolimus 6Cytarabine 6Specimen Handling 5Sirolimus 5Ipilimumab 5Clofarabine 5CTLA-4 Antigen 5Antilymphocyte Serum 5belinostat 4aldesleukin 4Thiotepa 4Standard of Care 4Practice Guidelines as Topic 4Mycophenolic Acid 4Methotrexate 4Magnetic Resonance Spectroscopy 4Interleukin-2 4Granulocyte Colony-Stimulating Factor 4Dexamethasone 4Busulfan 4Bortezomib 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Hematologic Neoplasms × Thiotepa × Clear all
NCT07257419 2026-05-19

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

St. Jude Children's Research Hospital

Phase 1 Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07052370 2025-12-31

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 1 Recruiting
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03885947 2021-05-24

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
7 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT00824135 2017-01-02

Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 1 Completed
34 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡